Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Arvind Dasari's publication output changed over time?
ScholarIQpublication output · 2012–2023
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2023.
1
1
3
1
1
2
1
1
20122015201720182019202020212023
What are the most-cited papers on Arvind Dasari?
ScholarIQmost cited works
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari, Chan Shen, Daniel M. Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, Ya‐Chen Tina Shih, James C. Yao
JAMA Oncology. 20173,498 CitationsOPEN ACCESS
Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer
Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz
Journal of Clinical Oncology. 2015697 CitationsOPEN ACCESS
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav
JAMA Oncology. 2019573 CitationsOPEN ACCESS
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Satya Das, Arvind Dasari
S83206718. 2021391 CitationsOPEN ACCESS
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
Daniel M. Halperin, Chan Shen, Arvind Dasari, Ying Xu, Yiyi Chu, Shouhao Zhou, Ya‐Chen Tina Shih, James C. Yao
The Lancet Oncology. 2017388 Citations
Related on ScholarIQ
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Paper
Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer
Paper
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
Paper
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Paper
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
Paper
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
Paper